OBSERVE MEDICAL Aktie

 

Oslo, 4 July Reference is made to the stock exchange announcement by Observe Medical ASA (the "Company" or "Observe Medical", OSE ticker "OBSVR") on 1 July 2025, regarding the board of directors' resolution to increase the share capital of the Company by the issuance of 6,000,000 new shares to Jiangsu Hongxin Medical Technology Co. Ltd ("Jiangsu") in connection with the private placement, at a subscription price of NOK 0.50 per share (the "Jiangsu Conversion Shares") through set-off against a receivable amounting to NOK 3,000,000 that Jiangsu had against the Company (following transfer...

Oslo, 3 July 2025 Reference is made to the stock exchange announcement by Observe Medical ASA ("Observe Medical" or the "Company", OSE ticker: OBSVR)) on 12 June 2025, regarding notice of an extraordinary general meeting in connection with, inter alia, a private placement (including a loan conversion to be completed by Navamedic ASA) and a contemplated subsequent offering in the Company. The extraordinary general meeting was held today, on 3 July 2025, at 14:00 hours (CEST). All resolutions proposed by the Company's board of directors were approved, including (i) the issuance of 56,...

Oslo, 3 July 2025 Reference is made to the stock exchange announcement by Observe Medical ASA ("Observe Medical" or the "Company", OSE ticker: OBSVR) on 11 June 2025 regarding the successfully placed private placement (the "Private Placement") of 72,890,000 new shares in the Company (the "Offer Shares") at a subscription price of NOK 0.50 per Offer Share for gross proceeds totalling NOK 36,445,000. As stated in the announcement, the completion of the Private Placement was, inter alia, subject to the extraordinary general meeting of the Company (the "EGM") resolving to increase the...

Oslo, 1 July 2025 Observe Medical ASA ("Observe Medical" or the "Company", OSE ticker "OBSVR") is pleased to announce the strengthening of its strategic partnership with its key manufacturing partner, Jiangsu Hongxin Medical Technology Co. Ltd ("Jiangsu"), through Jiangsu's subscription for 6,000,000 shares in the Company. This agreement not only solidifies our collaboration but also delivers a significant positive liquidity effect, freeing up capital to accelerate the commercial rollout of UnoMeter. Reference is furhter made to the stock exchange announcement by Observe Medical ASA (...

Oslo, 1 July 2025 Observe Medical ASA ("Observe Medical" or the "Company", OSE ticker "OBSVR") is pleased to announce the strengthening of its strategic partnership with its key manufacturing partner, Jiangsu Hongxin Medical Technology Co. Ltd ("Jiangsu"), through Jiangsu's subscription for 6,000,000 shares in the Company. This agreement not only solidifies our collaboration but also delivers a significant positive liquidity effect, freeing up capital to accelerate the commercial rollout of UnoMeter. Reference is furthter made to the stock exchange announcement by Observe Medical ASA (...

Oslo, 1 July 2025 Reference is made to the stock exchange announcement by Observe Medical ASA ("Observe Medical" or the "Company", OSE ticker: OBSVR) on 27 June 2025, regarding, inter alia, the resolution of the annual general meeting to reduce the Company's share capital by way of reducing the nominal value of each share with NOK 3.48, from NOK 3.90 to NOK 0.42. The share capital reduction has today been registered in the Norwegian Register of Business Enterprises, and the Company's new share capital is NOK 8,088,533.04, divided into 19,258,412 shares, each with a nominal value of...

Oslo, 27 June 2025 The annual general meeting of Observe Medical ASA (the "Company" or "Observe Medical", Euronext Expand ticker "OBSRV") was held today, on 27 June 2025 at 10:00 hours (CEST), at Dronning Eufemias gate 16, 2nd floor, 0191 Oslo, Norway. All resolutions were made in accordance with the proposals from the board of directors and the nomination committee. The minutes from the general meeting is attached hereto and will also be available at www.observemedical.com. As set out in the minutes, the general meeting has resolved to reduce the Company's share capital by way...

Oslo, June 24, 2025 – Observe Medical ("the Company" or "Observe Medical") is pleased to announce that UnoMeter[TM] Safeti[TM] Plus has been appointed exclusive winner of the tender in the largest region in Sweden, representing approximately 20% of the total Swedish market. In Finland UnoMeter[TM] Safeti[TM] has been awarded the tender for Helsinki and Tampere which represents approx. 20% of the Finnish market, on a non-exclusive basis. In Denmark supply contracts has been signed and deliveries have commenced to 3 out of 5 healthcare regions, representing nearly 60% of the national market....

Oslo, 12 June 2025 Reference is made to the announcement made by Observe Medical ASA (the "Company" or "Observe Medical", and, together with its subsidiaries, the "Group", OSE ticker "OBSRV") on 11 June 2025, regarding the successfully placed private placement of new shares in the Company to raise gross proceeds totalling NOK 36,445,000 (the "Private Placement"). An extraordinary general meeting of the Company will be held on 3 July 2025 at 14:00 (CEST) (the "EGM"). The notice of the EGM, including agenda, proposed resolutions, registration form, a form of proxy and other relevant...

Issuer name: Observe Medical ASA Ex. date: 12 June 2025 Type of corporate action: Subsequent offering/repair issue Other information: Reference is made to the stock exchange announcement published by Observe Medical ASA on 11 June 2025 with key information relating to the subsequent offering.   This information is published in accordance with the requirements of the Continuing Obligations....

NOT FOR DISTRIBUTION, PUBLICATION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, JAPAN, HONG KONG, SOUTH AFRICA OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION, PUBLICATION OR RELEASE WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Oslo, 11 June 2025 Reference is made to the stock exchange announcement by Observe Medical ASA ("Observe Medical" or the "Company", OSE ticker: OBSVR) earlier today, regarding the placement of a conditional private placement (the "...

NOT FOR DISTRIBUTION, PUBLICATION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, JAPAN, HONG KONG, SOUTH AFRICA OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION, PUBLICATION OR RELEASE WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Oslo, 11 June 2025 Reference is made to the previous stock exchange announcement made by Observe Medical ASA (the "Company" or "Observe Medical", Euronext Expand ticker "OBSRV") regarding a contemplated private placement (the “...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN, HONG KONG OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN Oslo, 11 June 2025 Observe Medical ASA ("Observe Medical" or the "Company", OSE ticker: OBSVR) hereby announces a contemplated private placement to raise gross proceeds of NOK 30-40 million (the “Offer Size”, including the Debt Conversions, as defined below)...

Oslo, 6 June 2025 - Observe Medical ASA (OBSRV): The annual general meeting of Observe Medical ASA will be held on Friday, 27 June 2025, at 10:00 (CEST). The annual general meeting will be held at Dronning Eufemias gate 16, 2nd floor, 0191 Oslo, Norway. The notice of the annual general meeting is attached, together with the attendance and proxy forms. The notice has been sent to shareholders with known addresses, and is also available on the Company's website www.observemedical.com. For further information, please contact: Jørgen Mann, CEO Observe Medical Mobile: +45 408 67...

Oslo, May 30, 2025 – Observe Medical ("the Company" or "Observe Medical") has today published its Annual Report for 2024.  Observe Medical has today released its Annual Report 2024, including the Board of Directors report and financial statements. The report and annual accounts were approved by the Board of Directors on May 29, 2025. On 18 March 2025 Observe Medical reported preliminary and unaudited results for the second half year and full year 2024. Today's audited accounts include adjustments followed by the final conclusions received by the Norwegian Financial Supervisory...

Oslo, May 14, 2025 – Observe Medical ASA («Observe Medical» or the «Company») refers to the stock exchange announcement dated 25 October 2024, regarding the preliminary letter from the Norwegian Financial Supervisory Authority («NFSA» or «Finanstilsynet») on the review of the Company's financial reporting. Reference is also made to section 4.3.2 of the prospectus published by the Company on 19 November 2024 in which the preliminary letter from the NFSA is described in more detail. The NFSA has issued a final decision and upholds its preliminary decision described in detail in the...

Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: Anmerkungen NO0010865009 Observe Medical ASA 13.01.2025 NO0013457952 Observe Medical ASA 14.01.2025 Tausch 15:1...